Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel therapeutics that target cancer stem cells (CSCs) and tumor bulk. Stemline is developing two clinical stage product candidates, SL-401 and SL-701, and a pipeline of preclinical candidates that includes SL-801.

Contact This Clinic
About Us
  • For-profit or non-profit? For Profit
  • Size 10-50
  • Cost $$$
  • Average length of stay 4 hours
  • Accredited by
  • Certifications
  • YouTube
Specialties
  • Veterinary
  • Cancer Stem Cell Therapy
Read Patient Reviews For Stemline Therapeutics, Inc.

There are no reviews forStemline Therapeutics, Inc..




Get our newsletter for the latest news & updates.

Share the knowledge: